DEF: HAIA Seeks Extension for China Insurance Merger

Healthcare AI Acquisition Corp. (HAIA) is seeking shareholder approval to extend its business combination deadline to March 14, 2026, to complete its merger with China-based Leading Group Limited.

Summary

• HAIA is holding an Annual General Meeting on October 6, 2025, to vote on three proposals: extending the business combination deadline, ratifying auditors, and adjourning the meeting if needed.
• The primary proposal is to amend the Articles of Association to extend the deadline for completing a business combination from October 14, 2025, to March 14, 2026.
• The Sponsor, Atticus Ale LLC, will contribute $0.10 per non-redeemed Class A ordinary share per month to the trust account for each monthly extension, as a loan repayable upon business combination.
• HAIA has identified Leading Group Limited, a China-based independent insurance channel specialist, as its business combination target, with an agreement signed on August 15, 2024.
• The proposed business combination values Leading Group at $430,000,000, with equityholders receiving 43,000,000 Holdco Class A Ordinary Shares.
• As of September 17, 2025, the trust account holds approximately $1,910,690.19, and the redemption price per public share is approximately $12.53, while the OTC closing price was $11.72.
• HAIA was delisted from Nasdaq on December 17, 2024, for failing to complete a business combination within 36 months of its IPO and now trades on OTC.
• Significant redemptions have occurred previously, reducing the trust account balance from an initial $219,936,490 to the current $1,910,690.19.
• The Sponsor and initial shareholders own approximately 95% of the outstanding Ordinary Shares and intend to vote in favor of the extension.

Sentiment

Score: 3

Explanation: The company faces significant challenges, including delisting from Nasdaq, substantial redemptions, and the need for multiple extensions to complete a business combination. While a target has been identified and the sponsor is providing funding for the extension, the overall financial health and operational timeline are precarious.

Positives

• Identified a business combination target, Leading Group Limited, and entered into a Business Combination Agreement.
• Sponsor (Atticus Ale LLC) committed to contributing $0.10 per non-redeemed Class A ordinary share per month to the trust account to fund the extension, demonstrating continued support.
• The proposed business combination with Leading Group Limited is believed to provide significant benefits to shareholders.
• Underwriters (Citigroup Global Markets Inc. and Jefferies LLC) waived their deferred discount entitlement, reducing potential liabilities.

Negatives

• HAIA failed to complete a business combination within the required timeframe, leading to delisting from Nasdaq on December 17, 2024.
• Significant shareholder redemptions have drastically reduced the trust account balance from $219,936,490 to approximately $1,910,690.19 as of September 17, 2025.
• The current market price of HAIA Public Shares ($11.72 on OTC as of Sept 17, 2025) is lower than the redemption price ($12.53), indicating a potential loss for shareholders selling on the open market.
• Warrants will expire worthless if HAIA dissolves and liquidates the trust account.
• The company has already sought multiple extensions and experienced substantial redemptions.

Risks

• No assurance that the extension will enable HAIA to complete a business combination by the Extended Date (March 14, 2026).
• Redemptions in connection with the Extension Proposal could leave HAIA with insufficient cash to consummate the Proposed Business Combination on commercially acceptable terms, or at all.
• Risk of being deemed an investment company under the Investment Company Act of 1940, which could force liquidation and cause warrants to expire worthless.
• The Proposed Business Combination with a non-U.S. target (Leading Group in China) may be subject to U.S. foreign investment regulations and review by entities like CFIUS, potentially leading to delays, conditions, or prohibition of the merger.
• Delisting from Nasdaq and trading on OTC may reduce liquidity and make it difficult to maintain or obtain a national securities exchange listing.
• The Sponsor's working capital loans ($447,174 as of Dec 31, 2024) will be forfeited if the business combination does not close, except for funds outside the Trust Account.
• Initial Shareholders' Founder Shares (valued at $63,177,832) and Private Placement Warrants (valued at $333,748) would become worthless if a business combination is not consummated.

Future Outlook

HAIA intends to hold a separate Business Combination Annual General Meeting at a future date to approve the proposed merger with Leading Group Limited. If the Extension Proposal is approved, the company will continue efforts to consummate the business combination by March 14, 2026. If not approved, HAIA will cease operations, redeem public shares, and liquidate.

Management Comments

• The Board has determined that it is in the best interests of HAIA to seek an extension of the Termination Date and have HAIA shareholders approve the Extension Proposal because HAIA will be required to dissolve if the Extension Proposal is not approved and the currently required extension payments are not made.
• HAIA believes the Proposed Business Combination will provide significant benefits to its shareholders.
• The Board unanimously recommends that you vote or give instruction to vote FOR such proposals.
• HAIA believes that given HAIAs expenditure of time, effort and money on finding the Target for the Proposed Business Combination, it is in the best interests of HAIA and its shareholders that HAIA obtain the Extension.

Industry Context

The filing highlights the ongoing challenges faced by Special Purpose Acquisition Companies (SPACs) in completing business combinations within their mandated timelines, often leading to multiple extensions and significant shareholder redemptions. HAIA's delisting from Nasdaq and subsequent trading on OTC reflects a broader trend of increased scrutiny and difficulty for SPACs, particularly those with international targets that may face additional regulatory hurdles like CFIUS review. The proposed merger with a China-based insurance channel specialist indicates a strategic focus on the Asian market, a common target for SPACs seeking growth opportunities, but also introduces geopolitical and regulatory complexities.

Comparison to Industry Standards

• HAIA's repeated need for extensions and significant redemptions (reducing the trust account from $219.9M to $1.9M) is worse than industry standards, where successful SPACs typically complete mergers with fewer extensions and lower redemption rates.
• The delisting from Nasdaq and move to OTC is a negative indicator compared to peers that maintain major exchange listings, impacting liquidity and investor confidence.
• The proposed merger with Leading Group Limited, a China-based insurance specialist, is comparable to other SPACs targeting high-growth sectors and international markets, but the CFIUS risk highlights a specific challenge for cross-border deals involving sensitive industries or regions.
• The Sponsor's commitment to fund extensions is a common practice in SPACs facing deadline pressure, but the high cost per share ($0.10/month) and the substantial prior redemptions suggest a more distressed situation than typical.

Corporate Governance

Related Party Transactions

• Sponsor (Atticus Ale LLC) will contribute $0.10 per non-redeemed Class A ordinary share per month as a loan to the company for extensions, repayable upon business combination, and forgiven if the combination fails (except for funds held outside the Trust Account).
• Sponsor and Initial Shareholders own 5,390,600 Founder Shares (approximately 95% of Ordinary Shares) and 11,124,960 Private Placement Warrants, which would be worthless if the company liquidates.
• Sponsor issued working capital loans totaling $447,174 as of December 31, 2024, which may be repaid from funds outside the Trust Account upon business combination, otherwise forfeited.
• Directors and officers have interests in the Extension Proposal due to their ownership, directly or indirectly through the Sponsor, of Founder Shares and private placement warrants.

Stakeholder Impact

• Shareholders: Public shareholders face a decision to redeem their shares at $12.53 (above current market price of $11.72) or hold for the potential business combination, risking further dilution or loss if the merger fails. Founder shareholders and warrant holders risk losing their entire investment if the company liquidates.
• Sponsor/Initial Shareholders: Have significant financial interests tied to the completion of the business combination, including the value of Founder Shares and Private Placement Warrants, and repayment of working capital loans.
• Employees/Management: Continued employment and potential benefits from the business combination are contingent on the extension and successful merger.
• Creditors: Obligations under Cayman Islands law to provide for claims of creditors in case of liquidation.

Next Steps

• Hold Annual General Meeting on October 6, 2025, to vote on Extension Proposal, Ratification of Auditors Proposal, and Adjournment Proposal.
• If Extension Proposal is approved, amend Articles of Association to extend the business combination deadline to March 14, 2026.
• Continue efforts to consummate the proposed business combination with Leading Group Limited.
• Call an additional Annual General Meeting (Business Combination Annual General Meeting) at a future date to approve the proposed business combination.
• If Extension Proposal is not approved, cease operations, redeem public shares, and liquidate.

Key Dates

Recommendation

Given the company's delisting from Nasdaq, the drastic reduction in its trust account due to repeated redemptions, and the ongoing uncertainty surrounding the completion of its proposed business combination with a China-based entity (which carries additional CFIUS risks), the investment carries substantial risk. While the redemption price ($12.53) is currently above the OTC market price ($11.72), indicating an opportunity for public shareholders to exit at a premium, the overall trajectory and repeated delays suggest a high probability of further value erosion or eventual liquidation if the merger fails. The significant insider ownership (95%) and their incentive to approve the extension may not align with public shareholder interests, especially considering the history of redemptions. A seasoned investor would likely recommend selling to capture the redemption premium or avoid further risk.

Keywords

SPAC, Healthcare AI Acquisition Corp, HAIA, Business Combination, Extension, Leading Group Limited, China Insurance, Merger, Proxy Statement, SEC Filing, Redemption, Nasdaq Delisting, OTC Trading, Atticus Ale LLC, Corporate Governance, Shareholder Vote, Trust Account